TOVX·87164U508·US·equity·Healthcare - Biotechnology-13D/G
TOVX (THERIVA BIOLOGICS INC) is held by 12 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($88,161), UBS Group AG ($44,223), JANE STREET GROUP, LLC ($34,664). Net institutional sentiment: Mixed.
See how TOVX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer